cuprizone has been researched along with sirolimus in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, B; Baranzini, SE; Chang, A; Chomyk, AM; Deckard, SA; Doud, MK; Dutta, R; Edberg, DD; Fox, RJ; Li, M; Macklin, WB; Ribaudo, MV; Staugaitis, SM; Trapp, BD | 1 |
| Bercury, KK; Macklin, WB; Narayanan, SP; Popescu, DC; Sachs, HH | 1 |
| Bai, CB; Benson, E; Dutta, R; Edberg, D; Kidd, G; Macklin, WB; Medicetty, S; Roholt, A; Sun, S; Trapp, B | 1 |
| Horeczko, J; Lauderdale, K; Merchant, U; Tiwari-Woodruff, SK; Yamate-Morgan, H | 1 |
| Jeffries, MA; Mather, ML; Wood, TL | 1 |
1 review(s) available for cuprizone and sirolimus
| Article | Year |
|---|---|
The mechanistic target of rapamycin as a regulator of metabolic function in oligodendroglia during remyelination.
Topics: Animals; Cuprizone; Demyelinating Diseases; Humans; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Oligodendroglia; Remyelination; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
4 other study(ies) available for cuprizone and sirolimus
| Article | Year |
|---|---|
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.
Topics: Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Humans; Immunosuppressive Agents; Memory Disorders; Mice; MicroRNAs; Monoamine Oxidase Inhibitors; Multiple Sclerosis; Neurons; Postmortem Changes; Receptors, AMPA; RNA, Messenger; Sirolimus | 2013 |
A new model of cuprizone-mediated demyelination/remyelination.
Topics: Analysis of Variance; Animals; Basic Helix-Loop-Helix Transcription Factors; Body Weight; Brain; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Immunosuppressive Agents; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Myelin Sheath; Myelin-Oligodendrocyte Glycoprotein; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Receptor, Platelet-Derived Growth Factor alpha; Sirolimus | 2014 |
A mouse model for testing remyelinating therapies.
Topics: Animals; Axons; Brain; Calcium-Binding Proteins; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Gliosis; Immunosuppressive Agents; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Monoamine Oxidase Inhibitors; Myelin Proteolipid Protein; Regeneration; Sirolimus; Time Factors; Triiodothyronine; White Matter | 2016 |
Functional Effects of Cuprizone-Induced Demyelination in the Presence of the mTOR-Inhibitor Rapamycin.
Topics: Animals; Axons; Cell Differentiation; Corpus Callosum; Cuprizone; Demyelinating Diseases; Male; Mice, Inbred C57BL; Myelin Sheath; Oligodendroglia; Sirolimus; TOR Serine-Threonine Kinases | 2019 |